Novo Nordisk share repurchase programme
Analysis based on 41 articles · First reported May 26, 2026 · Last updated Jul 13, 2026
The share repurchase programme signals Novo Nordisk's confidence in its financial health and may support the stock price by reducing supply. The ongoing buyback is a routine capital allocation activity with modest market impact.
Novo Nordisk is executing a share repurchase programme of up to DKK 15 billion over 12 months starting 4 February 2026. Under a sub-programme initiated 6 May 2026, the company repurchases B shares for up to DKK 11.2 billion through 1 February 2027. As of 26 June 2026, Novo Nordisk has repurchased 22,009,179 B shares at an average price of DKK 268.02 per share, totaling DKK 5.9 billion. The company holds 39,194,480 B shares as treasury shares, representing 0.9% of share capital. The programme is conducted under EU Safe Harbour Rules.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard